ArticleJournal of robotic surgery2026
Robot-assisted resection of abdominal lymphatic malformations in children: a novel minimally invasive strategy for complex lesions.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic-assisted surgery (RAS) represents a promising emerging alternative to conventional laparoscopic surgery (LAS) for abdominal lymphatic malformations (ALMs). We aimed to evaluate the safety and efficacy of robotic-assisted resection of ALMs in pediatric patients. A retrospective analysis was performed on 134 children with ALMs who underwent surgery from December 2018 to December 2025 at the Department of General Surgery, Children's Hospital, Zhejiang University School of Medicine. Patients were stratified into two groups according to the surgical modality: the robot-assisted surgery (RAS) group (n = 57) and the laparoscopic surgery (LAS) group (n = 77). The RAS group achieved a higher rate of total intracorporeal cyst dissection (33 vs. 13) and intracorporeal intestinal resection with anastomosis (21 vs. 1), whereas the LAS group more commonly used extracorporeal procedures (31 vs. 0; 32 vs. 3), with significant differences in surgical approach distribution (P < 0.001). The total hospitalization cost was significantly higher in the RAS group than in the LAS group [68286 (60183, 72551) yuan vs. 19261 (15651, 23869) yuan, P < 0.001]. Postoperatively, four complications occurred in the RAS group, while seven complications were observed in the LAS group. RAS appears to be a safe and feasible minimally invasive approach for pediatric ALMs. For complex lesions, RAS may offer advantages in intracorporeal dissection, intestinal preservation, and perioperative recovery. It serves as a favorable minimally invasive alternative to open surgery for complex ALMs, though its higher hospitalization cost limits widespread routine clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.